A Guide for Pain Management in Developing Nations: The Diagnosis and Assessment of Pain in Cancer Patients
- Authors
-
-
Joseph V. Pergolizzi
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA 2Department of Anesthesiology, Georgetown University School of Medicine, Washington, D.C., USA 3Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA -
Gianpietro Zampogna
NEMA Research, Naples, Florida, USA -
Robert Taylor
NEMA Research, Naples, Florida, USA -
Marixa Guerrero
Medical Director of Instituto de Ortopedia Roosevelt, Bogota, Colombia -
Juan Quillermo Santacruz
Palliativist of Fundacion Santa fe, Bogota, Colombia -
Robert B. Raffa
Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA
-
- Keywords:
- Cancer pain, malignant pain, opioid analgesia, opioids, undertreatment of cancer pain, assessment of cancer pain.
- Abstract
-
The fundamental approach to cancer patients with pain is to identify the pain sites, and describe, quantify, and categorize the pain by type at each site. There are many validated tools to serve the clinician in these efforts, particularly for pain assessment. Multimechanistic pain syndromes are common in cancer patients. Cancer patients may experience nociceptive pain. They may also experience neuropathic pain due to chemotherapy-induced or cancer-related nerve damage. Analgesic choices must be guided by the pain mechanisms, nature, and severity of the pain, comorbid conditions, and patient characteristics. Long-acting opioid analgesics or fixed-clock dosing can eliminate end-of-dose analgesic gaps. The potential for opioid abuse is an important public health challenge but one that should not undermine the appropriate treatment of moderate to severe cancer pain. Abuse-deterrent opioid formulations can be useful. Care is needed for special populations of cancer patients dealing with pain, such as geriatric, pediatric, or obese patients. While morphine has long been the gold standard of oral opioid products, recent clinical trials suggest that oral hydrocodone and oral oxycodone may offer advantages over oral morphine. Patient adherence is crucial for adequate analgesia and patient education can promote adherence and manage expectations.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 14-01-2016
- Issue
- Vol. 5 No. 1 (2016)
- Section
- Articles
How to Cite
Similar Articles
- Dimple Sethi Chopra , Challenges in Development of Nanomedicine for Treatment of Cancer , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- Janet Wangari-Talbot, Elizabeth Hopper-Borge, Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Halkia Evgenia, Spiliotis John, Sugarbaker Paul, Second Look Proactive Surgery for Colon Cancer with Peritoneal Carcinomatosis , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- Abdulkareem Ahmed, Ahmed Nihad, Ghaeeb Sabreen, Youssef Shakuri Yasin, Jumaa Azal, Synergistic Antiproliferative Effect of Linagliptin-Metformin Combination on the Growth of Hela Cancer Cell Line , Journal of Cancer Research Updates: Vol. 14 (2025)
- Jun Yang, Bowei Chen, Jing Liu, Mobile Phone Based Healthcare Platform for Assisting Lung Cancer Prevention , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Marcos F. Dall’Oglio, Alexandre Crippa, Jose Roberto Colombo Junior, Rafael F. Coelho, Eder Nisi Ilário, Miguel Srougi, Nephron-Sparing Surgery in Renal Cell Carcinoma: Morbidity and Outcomes , Journal of Cancer Research Updates: Vol. 2 No. 3 (2013)
- M. Shankar Ganesh, R. Revanth, C. Mahesh Elaya Bharathi, Advanced Biomarkers and Precision Medicine: Innovative Strategies to Prevent Cancer Recurrence , Journal of Cancer Research Updates: Vol. 14 (2025)
- Yujiro Naruse, Surface Functionalization of Gold Nanoparticles for Simultaneous Suppression of Cancer Stem Cells and Cancer Cells , Journal of Cancer Research Updates: Vol. 3 No. 3 (2014)
- A. Lyberopoulou, E.P. Efstathopoulos, M. Gazouli, Nanodiagnostic and Nanotherapeutic Molecular Platforms for Cancer Management , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Francesco Ziglioli, Umberto Maestroni, The Oncological Outcome of HIFU for the Treatment of Localized Prostate Cancer , Journal of Cancer Research Updates: Vol. 3 No. 1 (2014)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Joseph V. Pergolizzi Jr., Robert B. Raffa, Emilio Esteban Gonzalez, Jo Ann LeQuang, A Guide for Cancer Pain Management in Latin America , Journal of Cancer Research Updates: Vol. 6 No. 4 (2017)
- Joseph V. Pergolizzi Jr, Robert Taylor Jr, Gianpietro Zampogna, Fuat H. Demirelli, Serdar Erdine, Robert B. Raffa, Oxycodone Immediate Release for Cancer Pain Management in Turkey: Maximizing Value in Opioid Analgesics , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)